

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | collagen fibril organization (GO:0030199) | 4.75391162 |
| 2 | wound healing, spreading of epidermal cells (GO:0035313) | 4.71049717 |
| 3 | chondrocyte proliferation (GO:0035988) | 4.61515379 |
| 4 | endodermal cell differentiation (GO:0035987) | 4.52538317 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.51027687 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.51027687 |
| 7 | response to peptidoglycan (GO:0032494) | 4.49055680 |
| 8 | protein heterotrimerization (GO:0070208) | 4.48847822 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 4.42819398 |
| 10 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.34221282 |
| 11 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.26224015 |
| 12 | cellular extravasation (GO:0045123) | 4.14476415 |
| 13 | basement membrane organization (GO:0071711) | 4.12831906 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.02296419 |
| 15 | skin morphogenesis (GO:0043589) | 3.99042033 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.93377965 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.93377965 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.87264341 |
| 19 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.81916347 |
| 20 | plasma membrane repair (GO:0001778) | 3.81777255 |
| 21 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.78227144 |
| 22 | wound healing, spreading of cells (GO:0044319) | 3.75101946 |
| 23 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.72954307 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.65225075 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.59419454 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.57725470 |
| 27 | apoptotic cell clearance (GO:0043277) | 3.56610967 |
| 28 | detection of other organism (GO:0098543) | 3.56351433 |
| 29 | regulation of tight junction assembly (GO:2000810) | 3.54162038 |
| 30 | epithelial cell-cell adhesion (GO:0090136) | 3.53242900 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52943939 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.49986427 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.44441506 |
| 34 | endothelial cell morphogenesis (GO:0001886) | 3.42236469 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.41956105 |
| 36 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.41352477 |
| 37 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.37323001 |
| 38 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.34110108 |
| 39 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.33029592 |
| 40 | axon extension involved in axon guidance (GO:0048846) | 3.33029592 |
| 41 | extracellular fibril organization (GO:0043206) | 3.29207768 |
| 42 | leukocyte aggregation (GO:0070486) | 3.28989538 |
| 43 | atrioventricular valve morphogenesis (GO:0003181) | 3.28209088 |
| 44 | negative regulation of interleukin-8 production (GO:0032717) | 3.27539110 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.27013089 |
| 46 | detection of bacterium (GO:0016045) | 3.25374309 |
| 47 | collagen metabolic process (GO:0032963) | 3.23231697 |
| 48 | substrate-dependent cell migration (GO:0006929) | 3.20933206 |
| 49 | fibril organization (GO:0097435) | 3.20087326 |
| 50 | negative regulation of fatty acid transport (GO:2000192) | 3.19897518 |
| 51 | stress fiber assembly (GO:0043149) | 3.15474389 |
| 52 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.15168638 |
| 53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.14455016 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.14344674 |
| 55 | sarcomere organization (GO:0045214) | 3.13916621 |
| 56 | collagen catabolic process (GO:0030574) | 3.13245594 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.12826287 |
| 58 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.12094122 |
| 59 | response to host (GO:0075136) | 3.09550172 |
| 60 | response to host defenses (GO:0052200) | 3.09550172 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.09550172 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09268692 |
| 63 | dermatan sulfate biosynthetic process (GO:0030208) | 3.09241204 |
| 64 | neutrophil activation (GO:0042119) | 3.09008019 |
| 65 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.08342333 |
| 66 | glomerular basement membrane development (GO:0032836) | 3.04608157 |
| 67 | extracellular matrix disassembly (GO:0022617) | 3.04492793 |
| 68 | lymphangiogenesis (GO:0001946) | 3.03476775 |
| 69 | regulation of leukocyte degranulation (GO:0043300) | 3.02591159 |
| 70 | detection of biotic stimulus (GO:0009595) | 3.01325379 |
| 71 | neutrophil mediated immunity (GO:0002446) | 3.01132895 |
| 72 | endocardial cushion development (GO:0003197) | 3.00368769 |
| 73 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.99081860 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.98797282 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98706642 |
| 76 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.97925329 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97285306 |
| 78 | regulation of macrophage cytokine production (GO:0010935) | 2.97078136 |
| 79 | peptidyl-proline hydroxylation (GO:0019511) | 2.95249333 |
| 80 | cellular response to interferon-alpha (GO:0035457) | 2.95082704 |
| 81 | cell-substrate junction assembly (GO:0007044) | 2.93470606 |
| 82 | response to host immune response (GO:0052572) | 2.92584959 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.92584959 |
| 84 | bone trabecula formation (GO:0060346) | 2.92205207 |
| 85 | negative regulation of interleukin-6 production (GO:0032715) | 2.91968676 |
| 86 | keratan sulfate catabolic process (GO:0042340) | 2.91955314 |
| 87 | hippo signaling (GO:0035329) | 2.90027636 |
| 88 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.87487155 |
| 89 | multicellular organismal catabolic process (GO:0044243) | 2.85951470 |
| 90 | germinal center formation (GO:0002467) | 2.85655636 |
| 91 | renal filtration (GO:0097205) | 2.83371104 |
| 92 | cardiac myofibril assembly (GO:0055003) | 2.83141808 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82848971 |
| 94 | fibroblast migration (GO:0010761) | 2.81392514 |
| 95 | multicellular organismal metabolic process (GO:0044236) | 2.81383950 |
| 96 | tolerance induction (GO:0002507) | 2.80042497 |
| 97 | dermatan sulfate metabolic process (GO:0030205) | 2.79575017 |
| 98 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.79554595 |
| 99 | cell migration involved in heart development (GO:0060973) | 2.79225413 |
| 100 | positive regulation of osteoblast proliferation (GO:0033690) | 2.78867767 |
| 101 | granulocyte activation (GO:0036230) | 2.78795609 |
| 102 | macrophage activation (GO:0042116) | 2.78526235 |
| 103 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.75739671 |
| 104 | hypotonic response (GO:0006971) | 2.72617529 |
| 105 | low-density lipoprotein particle clearance (GO:0034383) | 2.71127618 |
| 106 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70782601 |
| 107 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.69304187 |
| 108 | microglial cell activation (GO:0001774) | 2.68872274 |
| 109 | protein hydroxylation (GO:0018126) | 2.67741764 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66175768 |
| 111 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.65988452 |
| 112 | barbed-end actin filament capping (GO:0051016) | 2.65462467 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.64707578 |
| 114 | atrial septum morphogenesis (GO:0060413) | 2.64686078 |
| 115 | negative regulation of phagocytosis (GO:0050765) | 2.63581079 |
| 116 | glomerular filtration (GO:0003094) | 2.62980999 |
| 117 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.62956005 |
| 118 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.62819611 |
| 119 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.62777958 |
| 120 | mannose metabolic process (GO:0006013) | 2.62603072 |
| 121 | protein localization to cell surface (GO:0034394) | 2.62309030 |
| 122 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.62126481 |
| 123 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.62014505 |
| 124 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.60311872 |
| 125 | response to progesterone (GO:0032570) | 2.60148813 |
| 126 | response to fluid shear stress (GO:0034405) | 2.59404370 |
| 127 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.57918166 |
| 128 | negative regulation of protein autophosphorylation (GO:0031953) | 2.57292539 |
| 129 | hemidesmosome assembly (GO:0031581) | 2.56847964 |
| 130 | actin-myosin filament sliding (GO:0033275) | 2.55979159 |
| 131 | muscle filament sliding (GO:0030049) | 2.55979159 |
| 132 | adherens junction assembly (GO:0034333) | 2.55384460 |
| 133 | regulation of tolerance induction (GO:0002643) | 2.55352298 |
| 134 | extracellular matrix organization (GO:0030198) | 2.54411274 |
| 135 | pinocytosis (GO:0006907) | 2.53479555 |
| 136 | extracellular structure organization (GO:0043062) | 2.53194819 |
| 137 | response to laminar fluid shear stress (GO:0034616) | 2.52369354 |
| 138 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52287452 |
| 139 | regulation of cardioblast differentiation (GO:0051890) | 2.51204673 |
| 140 | regulation of regulated secretory pathway (GO:1903305) | 2.51151607 |
| 141 | platelet degranulation (GO:0002576) | 2.50069755 |
| 142 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.50068152 |
| 143 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50010086 |
| 144 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.49495912 |
| 145 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.49409964 |
| 146 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.49213901 |
| 147 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.48743762 |
| 148 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.48735548 |
| 149 | protein retention in ER lumen (GO:0006621) | 2.48461354 |
| 150 | immunoglobulin mediated immune response (GO:0016064) | 2.48110555 |
| 151 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.47882374 |
| 152 | myeloid cell activation involved in immune response (GO:0002275) | 2.47519851 |
| 153 | respiratory burst (GO:0045730) | 2.47187838 |
| 154 | craniofacial suture morphogenesis (GO:0097094) | 2.47034257 |
| 155 | extracellular matrix assembly (GO:0085029) | 2.46659545 |
| 156 | regulation of integrin activation (GO:0033623) | 2.46057196 |
| 157 | positive regulation of tolerance induction (GO:0002645) | 2.45928125 |
| 158 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.45746697 |
| 159 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.44767910 |
| 160 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.44767910 |
| 161 | regulation of mast cell activation (GO:0033003) | 2.43590303 |
| 162 | angiogenesis involved in wound healing (GO:0060055) | 2.43292942 |
| 163 | myeloid leukocyte mediated immunity (GO:0002444) | 2.42666720 |
| 164 | negative regulation of T cell mediated immunity (GO:0002710) | 2.41621183 |
| 165 | mRNA transcription (GO:0009299) | 2.41602815 |
| 166 | endothelial cell proliferation (GO:0001935) | 2.40414720 |
| 167 | hyaluronan catabolic process (GO:0030214) | 2.40361022 |
| 168 | glomerular visceral epithelial cell development (GO:0072015) | 2.39871976 |
| 169 | mesodermal cell differentiation (GO:0048333) | 2.39436378 |
| 170 | embryonic process involved in female pregnancy (GO:0060136) | 2.39235262 |
| 171 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.38975548 |
| 172 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.38840888 |
| 173 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.37947399 |
| 174 | negative regulation of type 2 immune response (GO:0002829) | 2.37809408 |
| 175 | regulation of T cell tolerance induction (GO:0002664) | 2.37256070 |
| 176 | positive regulation of mast cell activation (GO:0033005) | 2.36904387 |
| 177 | cellular response to vitamin (GO:0071295) | 2.36487651 |
| 178 | positive regulation of extracellular matrix organization (GO:1903055) | 2.36233425 |
| 179 | actin-mediated cell contraction (GO:0070252) | 2.35846826 |
| 180 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.35368176 |
| 181 | modulation by symbiont of host immune response (GO:0052553) | 2.35368176 |
| 182 | modulation by symbiont of host defense response (GO:0052031) | 2.35368176 |
| 183 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.35368176 |
| 184 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.34689006 |
| 185 | positive regulation of receptor recycling (GO:0001921) | 2.32591759 |
| 186 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.30834153 |
| 187 | negative regulation of interleukin-1 production (GO:0032692) | 2.29884233 |
| 188 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.29859286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.22136349 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.63554365 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.81468594 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.44950920 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.16495969 |
| 6 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.93964892 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.88793084 |
| 8 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.81549569 |
| 9 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.66590873 |
| 10 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.60467636 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.52819911 |
| 12 | CJUN_26792858_Chip-Seq_BT549_Human | 2.49656556 |
| 13 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.47784698 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.42867366 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41758577 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37136565 |
| 17 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31788607 |
| 18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.23884987 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19058145 |
| 20 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17940630 |
| 21 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.17908621 |
| 22 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.11319759 |
| 23 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09566674 |
| 24 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.06512485 |
| 25 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.06512485 |
| 26 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.05083730 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04158870 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.03968208 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.99108650 |
| 30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.95173230 |
| 31 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93552445 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92598499 |
| 33 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.92427395 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91128273 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88841448 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.87993924 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.87993924 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86995663 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86489231 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84397823 |
| 41 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.83691690 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82165986 |
| 43 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80066851 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77526378 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76170161 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.75673259 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.74389425 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71540300 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.70751927 |
| 50 | * MAF_26560356_Chip-Seq_TH1_Human | 1.70454541 |
| 51 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70383273 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70044865 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.66455765 |
| 54 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.64980438 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61504327 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.60574720 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59340644 |
| 58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.58383781 |
| 59 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.57580351 |
| 60 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.55510690 |
| 61 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54428476 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.53944197 |
| 63 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.53846823 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53733574 |
| 65 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51801041 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50384725 |
| 67 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49634981 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48232085 |
| 69 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.47822611 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.47822611 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46856848 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46772061 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46547628 |
| 74 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.45605778 |
| 75 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45172695 |
| 76 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.44442521 |
| 77 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44152800 |
| 78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43823709 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.39736567 |
| 80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.38721964 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38213643 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36636412 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35591246 |
| 84 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35577741 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33560169 |
| 86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.30013266 |
| 87 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.29975202 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29836412 |
| 89 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27835256 |
| 90 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.25974217 |
| 91 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24768073 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24156717 |
| 93 | * MYB_26560356_Chip-Seq_TH2_Human | 1.22959603 |
| 94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22380068 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22058473 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21379912 |
| 97 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20358261 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20276692 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 1.19857195 |
| 100 | * MYB_26560356_Chip-Seq_TH1_Human | 1.18373536 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17887616 |
| 102 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17132966 |
| 103 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.16911022 |
| 104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16339016 |
| 105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15627106 |
| 106 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.15509209 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13537498 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12615621 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12535145 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12078914 |
| 111 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10108369 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10084334 |
| 113 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08268524 |
| 114 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.07877208 |
| 115 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.07751496 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06640896 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06364042 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04938813 |
| 119 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04136853 |
| 120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04130616 |
| 121 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03992347 |
| 122 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03554595 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03005303 |
| 124 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02583831 |
| 125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02473059 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01615200 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01069891 |
| 128 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.00879769 |
| 129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00239330 |
| 130 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99206280 |
| 131 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98560770 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98467280 |
| 133 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97796850 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97703741 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96523968 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96241795 |
| 137 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96209416 |
| 138 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96169846 |
| 139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95580913 |
| 140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95013352 |
| 141 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94881035 |
| 142 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92872919 |
| 143 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90972819 |
| 144 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.90251390 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89090323 |
| 146 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.89008170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.42051787 |
| 2 | MP0005275_abnormal_skin_tensile | 4.01456750 |
| 3 | MP0005503_abnormal_tendon_morphology | 3.97485599 |
| 4 | MP0003279_aneurysm | 3.74824550 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.73948789 |
| 6 | MP0004272_abnormal_basement_membrane | 2.97438741 |
| 7 | MP0003566_abnormal_cell_adhesion | 2.97228900 |
| 8 | MP0001958_emphysema | 2.91820895 |
| 9 | MP0002419_abnormal_innate_immunity | 2.37028229 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.35850195 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.32603361 |
| 12 | MP0005623_abnormal_meninges_morphology | 2.22308901 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.07276273 |
| 14 | MP0006054_spinal_hemorrhage | 2.02000840 |
| 15 | MP0003828_pulmonary_edema | 1.99252903 |
| 16 | MP0005023_abnormal_wound_healing | 1.98638096 |
| 17 | MP0004084_abnormal_cardiac_muscle | 1.95586943 |
| 18 | MP0009384_cardiac_valve_regurgitation | 1.94096546 |
| 19 | MP0005257_abnormal_intraocular_pressure | 1.92919851 |
| 20 | MP0003091_abnormal_cell_migration | 1.90199267 |
| 21 | MP0005025_abnormal_response_to | 1.86716735 |
| 22 | MP0000685_abnormal_immune_system | 1.83845564 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.78667745 |
| 24 | MP0005508_abnormal_skeleton_morphology | 1.77506924 |
| 25 | MP0000767_abnormal_smooth_muscle | 1.67577784 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.66712940 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.65488591 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.65320502 |
| 29 | MP0001542_abnormal_bone_strength | 1.64634653 |
| 30 | MP0004947_skin_inflammation | 1.64399471 |
| 31 | MP0001851_eye_inflammation | 1.61848003 |
| 32 | MP0001879_abnormal_lymphatic_vessel | 1.60960056 |
| 33 | MP0009785_altered_susceptibility_to | 1.57441478 |
| 34 | MP0002132_abnormal_respiratory_system | 1.56019796 |
| 35 | MP0006082_CNS_inflammation | 1.55049366 |
| 36 | MP0002295_abnormal_pulmonary_circulatio | 1.53740938 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.53543703 |
| 38 | MP0001790_abnormal_immune_system | 1.53514770 |
| 39 | MP0005387_immune_system_phenotype | 1.53514770 |
| 40 | MP0002405_respiratory_system_inflammati | 1.53353883 |
| 41 | MP0000343_altered_response_to | 1.53022468 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.53014314 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.53000838 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.51264149 |
| 45 | MP0001819_abnormal_immune_cell | 1.49976298 |
| 46 | MP0002723_abnormal_immune_serum | 1.48893788 |
| 47 | MP0001800_abnormal_humoral_immune | 1.48626712 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.46442177 |
| 49 | MP0003303_peritoneal_inflammation | 1.45258193 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.43724373 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.43547576 |
| 52 | MP0005390_skeleton_phenotype | 1.42491005 |
| 53 | MP0003941_abnormal_skin_development | 1.42364095 |
| 54 | MP0002060_abnormal_skin_morphology | 1.42262498 |
| 55 | MP0000751_myopathy | 1.41556132 |
| 56 | MP0000733_abnormal_muscle_development | 1.40650993 |
| 57 | MP0002933_joint_inflammation | 1.33747569 |
| 58 | MP0008260_abnormal_autophagy | 1.31514734 |
| 59 | MP0000749_muscle_degeneration | 1.31003062 |
| 60 | MP0008775_abnormal_heart_ventricle | 1.29901927 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.28686899 |
| 62 | MP0005330_cardiomyopathy | 1.24534777 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.23245590 |
| 64 | MP0003075_altered_response_to | 1.22400149 |
| 65 | MP0010030_abnormal_orbit_morphology | 1.20820287 |
| 66 | MP0009840_abnormal_foam_cell | 1.20575493 |
| 67 | MP0000516_abnormal_urinary_system | 1.20452267 |
| 68 | MP0005367_renal/urinary_system_phenotyp | 1.20452267 |
| 69 | MP0003385_abnormal_body_wall | 1.19283947 |
| 70 | MP0004087_abnormal_muscle_fiber | 1.19126757 |
| 71 | MP0002972_abnormal_cardiac_muscle | 1.18753409 |
| 72 | MP0010630_abnormal_cardiac_muscle | 1.17013246 |
| 73 | MP0004510_myositis | 1.15998615 |
| 74 | MP0003436_decreased_susceptibility_to | 1.15918370 |
| 75 | MP0006138_congestive_heart_failure | 1.15509524 |
| 76 | MP0003448_altered_tumor_morphology | 1.13895965 |
| 77 | MP0002108_abnormal_muscle_morphology | 1.11974348 |
| 78 | MP0003724_increased_susceptibility_to | 1.10962467 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.08873311 |
| 80 | MP0002166_altered_tumor_susceptibility | 1.07757497 |
| 81 | MP0001544_abnormal_cardiovascular_syste | 1.07739869 |
| 82 | MP0005385_cardiovascular_system_phenoty | 1.07739869 |
| 83 | MP0002896_abnormal_bone_mineralization | 1.07490356 |
| 84 | MP0002128_abnormal_blood_circulation | 1.07386179 |
| 85 | MP0009250_abnormal_appendicular_skeleto | 1.06982520 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.06645463 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 1.06417158 |
| 88 | MP0003763_abnormal_thymus_physiology | 1.05664249 |
| 89 | MP0002396_abnormal_hematopoietic_system | 1.05048091 |
| 90 | MP0000716_abnormal_immune_system | 1.04821976 |
| 91 | MP0001853_heart_inflammation | 1.04668897 |
| 92 | MP0001243_abnormal_dermal_layer | 1.04372697 |
| 93 | MP0002398_abnormal_bone_marrow | 1.03891114 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 1.03639566 |
| 95 | MP0003045_fibrosis | 1.01646355 |
| 96 | MP0005166_decreased_susceptibility_to | 1.01228381 |
| 97 | MP0001614_abnormal_blood_vessel | 0.99141607 |
| 98 | MP0005083_abnormal_biliary_tract | 0.99062488 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.99027075 |
| 100 | MP0005451_abnormal_body_composition | 0.99004446 |
| 101 | MP0005164_abnormal_response_to | 0.97362809 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.96869143 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 0.96749239 |
| 104 | MP0001545_abnormal_hematopoietic_system | 0.96749239 |
| 105 | MP0000858_altered_metastatic_potential | 0.96220748 |
| 106 | MP0009053_abnormal_anal_canal | 0.96179249 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 0.95186793 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.94948444 |
| 109 | MP0002925_abnormal_cardiovascular_devel | 0.94510373 |
| 110 | MP0010155_abnormal_intestine_physiology | 0.94214773 |
| 111 | MP0005595_abnormal_vascular_smooth | 0.93172473 |
| 112 | MP0009764_decreased_sensitivity_to | 0.92069288 |
| 113 | MP0000163_abnormal_cartilage_morphology | 0.90864322 |
| 114 | MP0005620_abnormal_muscle_contractility | 0.90638647 |
| 115 | MP0002282_abnormal_trachea_morphology | 0.90252087 |
| 116 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89804134 |
| 117 | MP0008469_abnormal_protein_level | 0.89637645 |
| 118 | MP0004883_abnormal_blood_vessel | 0.88372185 |
| 119 | MP0002722_abnormal_immune_system | 0.87964289 |
| 120 | MP0000759_abnormal_skeletal_muscle | 0.87678708 |
| 121 | MP0002168_other_aberrant_phenotype | 0.87142008 |
| 122 | MP0008004_abnormal_stomach_pH | 0.85062695 |
| 123 | MP0002429_abnormal_blood_cell | 0.84963576 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.84849621 |
| 125 | MP0001175_abnormal_lung_morphology | 0.84774081 |
| 126 | MP0005671_abnormal_response_to | 0.84724202 |
| 127 | MP0004036_abnormal_muscle_relaxation | 0.83720160 |
| 128 | MP0002115_abnormal_skeleton_extremities | 0.83676602 |
| 129 | MP0000249_abnormal_blood_vessel | 0.82712982 |
| 130 | MP0002113_abnormal_skeleton_development | 0.82426164 |
| 131 | MP0005409_darkened_coat_color | 0.81796081 |
| 132 | MP0002133_abnormal_respiratory_system | 0.81372606 |
| 133 | MP0005388_respiratory_system_phenotype | 0.81372606 |
| 134 | MP0009278_abnormal_bone_marrow | 0.81004754 |
| 135 | MP0002254_reproductive_system_inflammat | 0.80550418 |
| 136 | MP0000266_abnormal_heart_morphology | 0.80358092 |
| 137 | MP0004484_altered_response_of | 0.79731673 |
| 138 | MP0000703_abnormal_thymus_morphology | 0.79614987 |
| 139 | MP0005165_increased_susceptibility_to | 0.79527864 |
| 140 | MP0002009_preneoplasia | 0.78741312 |
| 141 | MP0000689_abnormal_spleen_morphology | 0.78471824 |
| 142 | MP0005369_muscle_phenotype | 0.77491978 |
| 143 | MP0003795_abnormal_bone_structure | 0.76031296 |
| 144 | MP0004233_abnormal_muscle_weight | 0.75557551 |
| 145 | MP0002106_abnormal_muscle_physiology | 0.73868551 |
| 146 | MP0003866_abnormal_defecation | 0.73393634 |
| 147 | MP0003115_abnormal_respiratory_system | 0.72428127 |
| 148 | MP0004858_abnormal_nervous_system | 0.70684876 |
| 149 | MP0000534_abnormal_ureter_morphology | 0.69033548 |
| 150 | MP0000428_abnormal_craniofacial_morphol | 0.68902969 |
| 151 | MP0000003_abnormal_adipose_tissue | 0.68252137 |
| 152 | MP0001915_intracranial_hemorrhage | 0.67771547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 7.30840485 |
| 2 | Premature rupture of membranes (HP:0001788) | 7.06928385 |
| 3 | Aortic dissection (HP:0002647) | 4.48640005 |
| 4 | Aortic aneurysm (HP:0004942) | 4.34802060 |
| 5 | Cerebral aneurysm (HP:0004944) | 4.33872578 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.06758742 |
| 7 | Shallow orbits (HP:0000586) | 3.93555077 |
| 8 | Vertebral compression fractures (HP:0002953) | 3.91144829 |
| 9 | Myositis (HP:0100614) | 3.90907260 |
| 10 | Ankle contracture (HP:0006466) | 3.90537691 |
| 11 | Cervical subluxation (HP:0003308) | 3.83417270 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.83001525 |
| 13 | Increased connective tissue (HP:0009025) | 3.82695418 |
| 14 | Soft skin (HP:0000977) | 3.82223770 |
| 15 | Atrophic scars (HP:0001075) | 3.70578161 |
| 16 | Peritonitis (HP:0002586) | 3.66605162 |
| 17 | Dilatation of the ascending aorta (HP:0005111) | 3.64136389 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.62371968 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.51298521 |
| 20 | Orchitis (HP:0100796) | 3.46396992 |
| 21 | Spinal rigidity (HP:0003306) | 3.36243041 |
| 22 | Broad metatarsal (HP:0001783) | 3.24950060 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 3.20989460 |
| 24 | Fragile skin (HP:0001030) | 3.18531164 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 3.17919878 |
| 26 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.17919878 |
| 27 | Amyloidosis (HP:0011034) | 3.17515333 |
| 28 | Wormian bones (HP:0002645) | 3.15509316 |
| 29 | Right ventricular cardiomyopathy (HP:0011663) | 3.14325616 |
| 30 | Wrist flexion contracture (HP:0001239) | 3.05998419 |
| 31 | Bladder diverticulum (HP:0000015) | 3.00410825 |
| 32 | Biconcave vertebral bodies (HP:0004586) | 2.97909370 |
| 33 | Type 1 muscle fiber predominance (HP:0003803) | 2.95315741 |
| 34 | Genu recurvatum (HP:0002816) | 2.92191395 |
| 35 | Short nail (HP:0001799) | 2.89962193 |
| 36 | Blue sclerae (HP:0000592) | 2.88726855 |
| 37 | Stomatitis (HP:0010280) | 2.87684984 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.86899488 |
| 39 | Optic neuritis (HP:0100653) | 2.77660536 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.77660536 |
| 41 | Vascular tortuosity (HP:0004948) | 2.77298999 |
| 42 | Mitral valve prolapse (HP:0001634) | 2.73908926 |
| 43 | Abnormality of dentin (HP:0010299) | 2.70093185 |
| 44 | Aneurysm (HP:0002617) | 2.62900562 |
| 45 | Muscle fiber splitting (HP:0003555) | 2.62231248 |
| 46 | Follicular hyperkeratosis (HP:0007502) | 2.54504166 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.50298851 |
| 48 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.47571867 |
| 49 | Arterial tortuosity (HP:0005116) | 2.47470135 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.47456340 |
| 51 | Abnormality of the acetabulum (HP:0003170) | 2.46234699 |
| 52 | Spondylolisthesis (HP:0003302) | 2.46126457 |
| 53 | Cellulitis (HP:0100658) | 2.44118454 |
| 54 | Neonatal short-limb short stature (HP:0008921) | 2.43831765 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.41210552 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.38568462 |
| 57 | Episodic fever (HP:0001954) | 2.37054558 |
| 58 | Ventricular tachycardia (HP:0004756) | 2.37045306 |
| 59 | Polygenic inheritance (HP:0010982) | 2.35912314 |
| 60 | Overgrowth (HP:0001548) | 2.35008059 |
| 61 | Difficulty climbing stairs (HP:0003551) | 2.33869895 |
| 62 | Hyperextensible skin (HP:0000974) | 2.32624810 |
| 63 | Recurrent fungal infections (HP:0002841) | 2.32319360 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.29130792 |
| 65 | Broad face (HP:0000283) | 2.26236946 |
| 66 | Obstructive sleep apnea (HP:0002870) | 2.25379905 |
| 67 | Slender build (HP:0001533) | 2.23943611 |
| 68 | Coxa vara (HP:0002812) | 2.23314787 |
| 69 | Lipoatrophy (HP:0100578) | 2.22502096 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.21669772 |
| 71 | Elbow flexion contracture (HP:0002987) | 2.21055432 |
| 72 | Increased IgE level (HP:0003212) | 2.20228255 |
| 73 | Gingivitis (HP:0000230) | 2.19732776 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19727284 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 2.19173556 |
| 76 | Abnormal delivery (HP:0001787) | 2.16876640 |
| 77 | Recurrent skin infections (HP:0001581) | 2.15405010 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14227041 |
| 79 | Obstructive lung disease (HP:0006536) | 2.14227041 |
| 80 | Increased density of long bones (HP:0006392) | 2.13086252 |
| 81 | Epistaxis (HP:0000421) | 2.10034516 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.09749952 |
| 83 | Distal lower limb amyotrophy (HP:0008944) | 2.09584424 |
| 84 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09386184 |
| 85 | Camptodactyly of toe (HP:0001836) | 2.08841904 |
| 86 | Sudden death (HP:0001699) | 2.08630984 |
| 87 | Beaking of vertebral bodies (HP:0004568) | 2.07233329 |
| 88 | Joint laxity (HP:0001388) | 2.05974552 |
| 89 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.05934942 |
| 90 | Scapular winging (HP:0003691) | 2.05416254 |
| 91 | Syringomyelia (HP:0003396) | 2.05017456 |
| 92 | Spinal cord lesions (HP:0100561) | 2.05017456 |
| 93 | Myocardial infarction (HP:0001658) | 2.04418721 |
| 94 | Joint stiffness (HP:0001387) | 2.04156862 |
| 95 | Urticaria (HP:0001025) | 2.03400106 |
| 96 | Hyporeflexia of lower limbs (HP:0002600) | 2.03241688 |
| 97 | Pulmonary infiltrates (HP:0002113) | 2.01120991 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01015861 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01015861 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01015861 |
| 101 | Disproportionate tall stature (HP:0001519) | 2.00860079 |
| 102 | Thin bony cortex (HP:0002753) | 2.00193753 |
| 103 | Gingival bleeding (HP:0000225) | 1.98913244 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 1.98815881 |
| 105 | Polycythemia (HP:0001901) | 1.97872851 |
| 106 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96568036 |
| 107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96568036 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96568036 |
| 109 | Hematochezia (HP:0002573) | 1.96084510 |
| 110 | Meningitis (HP:0001287) | 1.95893268 |
| 111 | Mucopolysacchariduria (HP:0008155) | 1.93996442 |
| 112 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93996442 |
| 113 | Upper limb amyotrophy (HP:0009129) | 1.93199518 |
| 114 | Distal upper limb amyotrophy (HP:0007149) | 1.93199518 |
| 115 | Abnormality of the calf musculature (HP:0001430) | 1.92909095 |
| 116 | Generalized amyotrophy (HP:0003700) | 1.92209281 |
| 117 | Vasculitis (HP:0002633) | 1.91370495 |
| 118 | Chest pain (HP:0100749) | 1.90775775 |
| 119 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90126567 |
| 120 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90126567 |
| 121 | Wide anterior fontanel (HP:0000260) | 1.89513663 |
| 122 | Atrial fibrillation (HP:0005110) | 1.88471647 |
| 123 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86793072 |
| 124 | Round ear (HP:0100830) | 1.86687043 |
| 125 | Fused cervical vertebrae (HP:0002949) | 1.86448950 |
| 126 | EMG: myopathic abnormalities (HP:0003458) | 1.85143155 |
| 127 | Mitral regurgitation (HP:0001653) | 1.84757615 |
| 128 | Bruising susceptibility (HP:0000978) | 1.83118068 |
| 129 | Platyspondyly (HP:0000926) | 1.82682307 |
| 130 | Venous abnormality (HP:0002624) | 1.82366117 |
| 131 | Aortic valve stenosis (HP:0001650) | 1.81804063 |
| 132 | Abnormality of the pericardium (HP:0001697) | 1.81745220 |
| 133 | Bowel diverticulosis (HP:0005222) | 1.80476861 |
| 134 | Hemoptysis (HP:0002105) | 1.80111439 |
| 135 | Nonimmune hydrops fetalis (HP:0001790) | 1.79743139 |
| 136 | Mesomelia (HP:0003027) | 1.79127430 |
| 137 | Primary atrial arrhythmia (HP:0001692) | 1.78426076 |
| 138 | Pulmonary artery stenosis (HP:0004415) | 1.77523270 |
| 139 | Osteopenia (HP:0000938) | 1.76905832 |
| 140 | Radial bowing (HP:0002986) | 1.76791552 |
| 141 | Spinal cord compression (HP:0002176) | 1.76698741 |
| 142 | Petechiae (HP:0000967) | 1.75358193 |
| 143 | Arterial thrombosis (HP:0004420) | 1.75067890 |
| 144 | Leukocytosis (HP:0001974) | 1.75027534 |
| 145 | Hypertriglyceridemia (HP:0002155) | 1.74196364 |
| 146 | Supraventricular arrhythmia (HP:0005115) | 1.73240615 |
| 147 | Hypoplastic ischia (HP:0003175) | 1.72997387 |
| 148 | Ectopia lentis (HP:0001083) | 1.72832904 |
| 149 | Persistence of primary teeth (HP:0006335) | 1.72758515 |
| 150 | Hand muscle atrophy (HP:0009130) | 1.72477788 |
| 151 | Abnormality of skull ossification (HP:0002703) | 1.70411886 |
| 152 | Asymmetric septal hypertrophy (HP:0001670) | 1.70101985 |
| 153 | Limb-girdle muscle atrophy (HP:0003797) | 1.67608527 |
| 154 | Flexion contracture of toe (HP:0005830) | 1.67590414 |
| 155 | Joint contractures involving the joints of the feet (HP:0100492) | 1.67590414 |
| 156 | Osteoarthritis (HP:0002758) | 1.67502056 |
| 157 | Abnormality of the peritoneum (HP:0002585) | 1.67219642 |
| 158 | Knee flexion contracture (HP:0006380) | 1.66082365 |
| 159 | Hip contracture (HP:0003273) | 1.65727042 |
| 160 | Decreased skull ossification (HP:0004331) | 1.65235261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.12880949 |
| 2 | TRIB3 | 3.15373984 |
| 3 | DDR2 | 2.86891773 |
| 4 | ERN1 | 2.85875513 |
| 5 | PRPF4B | 2.73777078 |
| 6 | RIPK4 | 2.73292550 |
| 7 | PIM2 | 2.52625201 |
| 8 | DMPK | 2.48370185 |
| 9 | TESK1 | 2.43520471 |
| 10 | MYLK | 2.43203681 |
| 11 | LATS2 | 2.40281049 |
| 12 | PDGFRA | 2.06256495 |
| 13 | EPHA2 | 2.03525991 |
| 14 | ZAP70 | 2.02306152 |
| 15 | LATS1 | 2.00110755 |
| 16 | PKN2 | 1.99639166 |
| 17 | TGFBR2 | 1.97275311 |
| 18 | LIMK1 | 1.93598104 |
| 19 | EPHB2 | 1.88164112 |
| 20 | MAP4K1 | 1.88012861 |
| 21 | FER | 1.86964932 |
| 22 | PTK2B | 1.86647759 |
| 23 | TYK2 | 1.86479491 |
| 24 | IRAK4 | 1.86395346 |
| 25 | TRPM7 | 1.79132262 |
| 26 | MAP3K3 | 1.73881409 |
| 27 | NEK9 | 1.70557384 |
| 28 | KDR | 1.68107422 |
| 29 | PRKD2 | 1.66481399 |
| 30 | PTK2 | 1.66349355 |
| 31 | PAK2 | 1.65376298 |
| 32 | STK24 | 1.60574452 |
| 33 | RIPK1 | 1.49310127 |
| 34 | FES | 1.48232981 |
| 35 | GRK6 | 1.47251449 |
| 36 | STK38L | 1.46699799 |
| 37 | BMX | 1.44567327 |
| 38 | LRRK2 | 1.43513308 |
| 39 | PAK4 | 1.40545130 |
| 40 | STK10 | 1.39454462 |
| 41 | STK3 | 1.37703964 |
| 42 | PIK3CA | 1.37359968 |
| 43 | MAP3K14 | 1.35586516 |
| 44 | SIK3 | 1.34751142 |
| 45 | RPS6KA4 | 1.34356006 |
| 46 | KIT | 1.31909969 |
| 47 | MARK2 | 1.31070954 |
| 48 | TNK2 | 1.30391507 |
| 49 | SMG1 | 1.23317737 |
| 50 | MAP3K1 | 1.21602116 |
| 51 | PAK3 | 1.21523759 |
| 52 | MAPKAPK3 | 1.20410053 |
| 53 | MET | 1.18109092 |
| 54 | TAOK2 | 1.18024334 |
| 55 | EPHA3 | 1.16660477 |
| 56 | MOS | 1.13794866 |
| 57 | BTK | 1.11712380 |
| 58 | MAPK7 | 1.11669103 |
| 59 | STK38 | 1.10804980 |
| 60 | SIK1 | 1.10754683 |
| 61 | MAP2K3 | 1.10602010 |
| 62 | ILK | 1.09933063 |
| 63 | ROCK1 | 1.08218905 |
| 64 | MAPK15 | 1.07838643 |
| 65 | MAP3K6 | 1.06863324 |
| 66 | TESK2 | 1.03260481 |
| 67 | PRKG2 | 1.00661039 |
| 68 | PTK6 | 0.97738914 |
| 69 | NME2 | 0.97115706 |
| 70 | HIPK2 | 0.96950675 |
| 71 | CSF1R | 0.94413230 |
| 72 | MAP3K13 | 0.92631917 |
| 73 | KSR2 | 0.92354595 |
| 74 | MAP3K7 | 0.91548693 |
| 75 | MAP2K1 | 0.91024241 |
| 76 | EPHB1 | 0.90493302 |
| 77 | TGFBR1 | 0.89056203 |
| 78 | PIK3CG | 0.88545993 |
| 79 | TIE1 | 0.88280190 |
| 80 | DAPK3 | 0.86847856 |
| 81 | IRAK1 | 0.86246962 |
| 82 | IKBKE | 0.84089712 |
| 83 | TBK1 | 0.81067707 |
| 84 | ZAK | 0.80539586 |
| 85 | ERBB3 | 0.80284400 |
| 86 | PDPK1 | 0.77387422 |
| 87 | FGFR4 | 0.74153370 |
| 88 | IRAK2 | 0.73818265 |
| 89 | RPS6KA2 | 0.72700722 |
| 90 | FRK | 0.71474379 |
| 91 | JAK2 | 0.71376613 |
| 92 | MAP3K5 | 0.70948716 |
| 93 | CDK6 | 0.70935052 |
| 94 | ABL2 | 0.69787949 |
| 95 | CSK | 0.69471587 |
| 96 | RPS6KL1 | 0.68863036 |
| 97 | RPS6KC1 | 0.68863036 |
| 98 | CDC42BPA | 0.68308832 |
| 99 | PLK2 | 0.68072903 |
| 100 | MAPK12 | 0.67757921 |
| 101 | ICK | 0.67102423 |
| 102 | FLT3 | 0.66155186 |
| 103 | FGFR1 | 0.64087315 |
| 104 | MAP3K11 | 0.63721366 |
| 105 | MTOR | 0.63598864 |
| 106 | SYK | 0.63128010 |
| 107 | YES1 | 0.63049517 |
| 108 | FGR | 0.62789912 |
| 109 | PDK1 | 0.61898552 |
| 110 | MAP3K2 | 0.60890872 |
| 111 | PDGFRB | 0.60787055 |
| 112 | GSK3A | 0.59609088 |
| 113 | LCK | 0.59335271 |
| 114 | MAPKAPK2 | 0.59214843 |
| 115 | PRKD1 | 0.59069419 |
| 116 | CDK12 | 0.58289657 |
| 117 | TAOK3 | 0.56753846 |
| 118 | IKBKB | 0.56728716 |
| 119 | NEK1 | 0.56479203 |
| 120 | NUAK1 | 0.55497920 |
| 121 | TEC | 0.53694490 |
| 122 | PAK1 | 0.53667271 |
| 123 | LMTK2 | 0.53053479 |
| 124 | RPS6KA6 | 0.53021324 |
| 125 | IRAK3 | 0.52473291 |
| 126 | JAK1 | 0.51891725 |
| 127 | CAMK1D | 0.51391846 |
| 128 | OBSCN | 0.51193019 |
| 129 | EIF2AK1 | 0.50418776 |
| 130 | LYN | 0.49151751 |
| 131 | MAP3K8 | 0.48084088 |
| 132 | DYRK1B | 0.47385622 |
| 133 | GRK7 | 0.46770478 |
| 134 | AKT3 | 0.46133360 |
| 135 | JAK3 | 0.45789175 |
| 136 | ITK | 0.45735941 |
| 137 | MARK3 | 0.43724315 |
| 138 | RET | 0.43680628 |
| 139 | EGFR | 0.42796249 |
| 140 | ROCK2 | 0.42457662 |
| 141 | HCK | 0.40879429 |
| 142 | NTRK1 | 0.40371013 |
| 143 | INSR | 0.39401840 |
| 144 | BLK | 0.38757316 |
| 145 | SRC | 0.37880675 |
| 146 | MST1R | 0.37850444 |
| 147 | PDK2 | 0.36433156 |
| 148 | FGFR3 | 0.36412328 |
| 149 | ABL1 | 0.35217373 |
| 150 | CAMKK1 | 0.34495772 |
| 151 | TAOK1 | 0.33672370 |
| 152 | IGF1R | 0.30055541 |
| 153 | PRKCE | 0.29624486 |
| 154 | RPS6KB2 | 0.29488753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.14615816 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.67962567 |
| 3 | Focal adhesion_Homo sapiens_hsa04510 | 2.65432250 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.47932929 |
| 5 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.36014779 |
| 6 | Adherens junction_Homo sapiens_hsa04520 | 2.32330282 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.25002550 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.19801662 |
| 9 | Amoebiasis_Homo sapiens_hsa05146 | 2.14161643 |
| 10 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.13792099 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.10269485 |
| 12 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.00286592 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.97154120 |
| 14 | Shigellosis_Homo sapiens_hsa05131 | 1.89164895 |
| 15 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.83458906 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.83336931 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.77758353 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.65334541 |
| 19 | Bladder cancer_Homo sapiens_hsa05219 | 1.65022867 |
| 20 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.55414739 |
| 21 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.54641414 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.54334412 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46965300 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.40946447 |
| 25 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.39976414 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39873393 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36250961 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.34666826 |
| 29 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.33011496 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.31438749 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31298141 |
| 32 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.31183200 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27756868 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26139394 |
| 35 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.24145896 |
| 36 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.23058058 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21541600 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18587434 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.17220066 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.16892784 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16631390 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16612311 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16012279 |
| 44 | Melanoma_Homo sapiens_hsa05218 | 1.15821238 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.15536449 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14621123 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.11577627 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.11331852 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.08643488 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04471496 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 1.03729880 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.02135338 |
| 53 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.00152003 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96318883 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93346999 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92222852 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91119541 |
| 58 | Pathways in cancer_Homo sapiens_hsa05200 | 0.90811728 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88856942 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87715157 |
| 61 | Prostate cancer_Homo sapiens_hsa05215 | 0.85953397 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84280723 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83504123 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82966056 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82375408 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.80987834 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.80804504 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80483088 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80040828 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79506969 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76195169 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75810962 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75697685 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75370299 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75234778 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.74890717 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74411580 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72984070 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72801153 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71137511 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69777093 |
| 82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69643959 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69513509 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.69123200 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68090014 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66906014 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.65808659 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64851486 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64353037 |
| 90 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.61520561 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60748282 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59530040 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59255354 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58914810 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57541406 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56305673 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56288022 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56037770 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54099538 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.53890539 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52567640 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51139158 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50623879 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50179530 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50084293 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49220507 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48797984 |
| 108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48751106 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48628077 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48232603 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47259531 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46424241 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46315559 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46182754 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.46163668 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45263446 |
| 117 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44555596 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44081485 |
| 119 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43964347 |
| 120 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43084532 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42696901 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.41396462 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.41238637 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41146156 |

